Which contraceptive methods are recommended for young women with type 1 diabetes mellitus? A survey among practitioners in Germany;Welches kontrazeptivum empfehlen sie einer jugendlichen mit typ I diabetes? Eine umfrage unter gynakologen/-innen

Zentralblatt fur Gynakologie

Volumn 120, Issue 11, 1998, Pages 540-544

  Manolopoulos, K ^a   Lang, U ^a   Schmitt, S ^a   Kirschbaum, M ^a   Kapellen, T ^a   Kiess, W ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Contraception; Female adolescents; Type 1 diabetes mellitus

Indexed keywords

ADOLESCENT; ARTICLE; ATTITUDE; CONDOM; CONTRACEPTION; FEMALE; GERMANY; HUMAN; HUMAN EXPERIMENT; INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; QUESTIONNAIRE; SAFETY;

EID: 0031740610     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Adams PW, Godsland I, Melrose J: The influence of oral contraceptive formulation on carbohydrate and lipid metabolism. J Pharmother 3 (1980) 54-58
2. American Diabetes Association. Clinical Practice Recommendations 1997. Diabetes Care 20 (1997) Supp. 1
3. Beck B: Contraceptive steroids: modification of carbohydrate and lipid metabolism. Metabolism 22 (1973) 841-855
4. Bettendorf G, Breckwoldt M, Keller PJ, Kuhl H, Runnebaum B: 14. Arbeitsreffen des ,Zürcher Gesprächskreises April 1995 - Empfehlung zur oralen Kontrazeption. Frauenarzt 36 (1995) 1002-1004
5. Briese V, Müller H: Diabetes Mellitus: Epidemiologische Studie zu Fertilität, Kontrazeption und Sterilität. Geburtshilfe Frauenheilkd 55 (1995) 270-274
6. Chabot V: Guidelines of the Swiss Diabetic Association on diabetes and contraception. Schweiz Rundsch Med Prax 20 (1986) 629-631
7. Parley MMT, Rosenberg JM, Rowe PJ, Chen JH, Meirik O: Intrauterine and pelvic inflammatory disease: an international perspective. Lancet 339 (1992) 785-788
8. Garg SK, Chase P, Marshall G, Hoops SL, Holmes DL, Jackson WE: Oral contraceptives and renal and retinal complications in young women with insulin-depent diabetes mellitus. JAMA 13 (1994) 1099-1102
9. Ho M, Marger M, Beart J, Yip I, Shekelle P: Is the quality of diabetic care better in a diabetes clinic or in a general medicine clinic? Diabetes Care 20 (1997) 472-475
10. Kay CR: The Royal College of General Practitioner's oral contraceptive study: some recent observations. Clin Obstet Gynecol 11 (1984) 759-787
11. Kimmerle R, Heinemann L, Berger M: Intrauterine devices are safe and effective contraceptives for type I diabetic women. Diabetes Care 11 (1995) 1506-1507
12. Kimmerle R, Schmitt G, Berger M: Empfängnisverhütung bei Typ I Diabetikerinnen. Eine Erhebung bei 808 Frauen im fertilen Alter. Geburtshilfe Frauenheilkd 54 (1994) 691-696
13. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD: Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA 265 (1991) 731-736
14. Kjaer K, Hagen C, Sandos H, Eshoy O: Contraception in women with IDDM. An epidemiological study. Diabetes Care 15 (1992) 1585-1590
15. Klein BEK, Moss SE, Klein R: Oral contraceptives in women with diabetes. Diabetes Care 13 (1990) 895-898
16. Kühn I: Ratschläge für die Praxis, Diabetes in der Schwangerschaft, Geburtshilfe Frauenheilkd 42 (1996) 225-230
17. Lucas MJ, Leveno KJ, Williams ML, Raskin P, Whalley PJ: Early pregnancy, glycosylated hemoglobin, severity of diabetes, and fetal malformations. Am J Obstet Gynecol 161 (1989) 426-431
18. Miller GJ, Miller NE: Plasma-high-density-Iipoprotein concentration and development of ischaemic heart disease. Lancet 1 (1975) 16-21
19. Miller E, Hare JW, Cloherty JP, Dunn PJ, Gleason RE, Soeldner JS et al.: Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N. Engl. J. Med. 304 (1981) 1331-1334.
20. Mills JL, Knopp RH, Simpson JL, Jovanovic-Peterson L., Metzger BE, Holmes LB et al.: Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 318 (1988) 671-676
21. Petersen KR, Vedel P, Skouby SO, Haaber AB: Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism. Diabetes Care (1995) 800-806
22. Petersen KR, Skouby SO, Jespersen J: Balance of coagulation activity with fibrinolysis during use of oral contraceptives with insulin-dependent diabetes mellitus. Int J Fert Menopausal Stud 40 (1995) Suppl. 2, 105-111
23. Radberg T, Gustafson A, Skryten A, Karlsson K: Oral contraception in diabetic women. Horm Metab Res 14 (1982) 61-65
24. Schmitt S, Burger D, Kühl PG, Kiess W: Diabetische Fetopathie. Monatsschr Kinderheilkd 144 (1996) 79-86
25. Scouby S, Molsted-Pedersen OL, Kühl C: Contraception in diabetic women. Acta Endocrinol 277 (1986) Suppl., 125-129
26. Sefaty D, Wildermeersch D, Verougstraete A, Creatsas G: European Society of Contraceptives survey update: birth control methods in "Europe of the 12". Int J Fertil Menopausal Stud 40 (1995) Suppl. 2, 73-79
27. Skouby S, Molsted-Pedersen OL, Kühl C, Bennet P: Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progesteron profiles. Fertil Steril 46 (1986) 858-864
28. Spellacy W: Carbohydrate metabolism during treatment with estrogen, progesteron, and low-dose oral contraceptives. Am J Obstet Gynecol 142 (1982) 732-734
29. Vessey MP, Lawless M, Yeates D: Efficacy of different contraceptive methods. Lancet II (1982) 842-892
30. Wilborn TA, Wearne K: Coronary heart disease in incidence and cardiovascular mortality in Busselton with reference glucose and insulin concentrations. Diabetes Care 2 (1979) 154-160
31. Wilson BE, Cruickshank J, McMaster M, Weir RJ: A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progesteron. Brit J Obst Gyn 91 (1984) 1254-1260